Cecilia Carnrot - Concepedia

Author

Cecilia Carnrot

Swedish University of Agricultural Sciences ORCID

Also Known As

C. Carnrot, Cecilia Carnrot

Publications

555

Citations

H-Index

Concepts

All Affiliations

Swedish University of Agricultural Sciences Novavax (Sweden)Jenner Institute University of Oxford Vector Oncology (United States)

About

Cecilia Carnrot is an author at Swedish University of Agricultural Sciences specializing in medicine, molecular biology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	132
2	Natural Sciences	3	3	79
3	Biochemistry	3	3	79
4	Chemical Biology	2	2	62
5	Cell Biology	1	1	35

Cecilia Carnrot

Publications

426

Citations

H-Index

Page 1

	Year	Citations
Structures of thymidine kinase 1 of human and mycoplasmic origin M. Welin, U. Kosinska, Nils-Egil Mikkelsen, Proceedings of the National Academy of Sciences	2004	138
Molecular characterization of thymidine kinase from <i>Ureaplasma urealyticum</i>: nucleoside analogues as potent inhibitors of <i>mycoplasma</i> growth Cecilia Carnrot, Rahma Wehelie, Staffan Eriksson, Molecular Microbiology Molecular CharacterizationBiosynthesisCellular EnzymologyBiochemistryNatural Sciences	2003	46
Structure of the substrate complex of thymidine kinase from <i>Ureaplasma urealyticum </i>and investigations of possible drug targets for the enzyme U. Kosinska, Cecilia Carnrot, Staffan Eriksson, FEBS Journal	2005	35
Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis Cecilia Carnrot, Kajsa E. Prokopec, Kristina Råsbo, Cellular and Molecular Immunology InflammationRheumatologyType IiRheumatoid DisorderAutoimmune Disease	2011	35
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial Sarah E. Silk, Wilmina F. Kalinga, Jo Salkeld, The Lancet Infectious Diseases	2024	34
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex Barnabas G. Williams, Lloyd D. W. King, David Pulido, Nature Communications	2024	26
Structural studies of thymidine kinases from <i>Bacillus anthracis</i> and <i>Bacillus cereus</i> provide insights into quaternary structure and conformational changes upon substrate binding U. Kosinska, Cecilia Carnrot, Michael P. B. Sandrini, FEBS Journal	2006	22
Synthesis and Biological Evaluation of Inhibitors of Thymidine Monophosphate Kinase from<i>Bacillus Anthracis</i> Youngjoo Byun, Susan R. Vogel, Andrew J. Phipps, Nucleosides Nucleotides & Nucleic Acids	2008	20
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies Lloyd D. W. King, David Pulido, Jordan R. Barrett, Cell Reports Medicine	2024	19
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults Alfred B. Tiono, Jordan Plieskatt, Alphonse Ouédraogo, Journal of Clinical Investigation VaccinationAdverse EventsVaccine DevelopmentCandidates R0.6cVaccine Research	2024	18

Page 1